Global Clot Management Devices Market By Product Type (Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis devices, Neurovascular Embolectomy Devices), End User (Hospitals, Diagnostic Centers)
Special Offering :
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
The global Clot Management Devices Market Size is expected to attain a market size of $1.7billion by 2022, growing at a CAGR of 5.0% during the forecast period.
Blood Clotting also known as coagulation is the body?s response to an injury to prevent bleeding. It prevents excessive bleeding when the blood vessels are injured. However, a clot can be harmful when it forms abnormal flows through the vessels. The excessive formation of clots in the blood leads to different diseases such as brain stroke, heart attack and severe leg pain. Blood Clot forms in one or more veins located deep inside a human body would lead to Deep Vein Thrombosis (DVT) and could damage an organ completely. Clot Management devices are used for the treatment of coronary thrombosis, periphery artery, arteriovenous, neurovascular and DVT. As per the World Health Organisation (WHO), more than 17 million people die annually from cardiovascular diseases. The main reason for cardiovascular diseases are increasing consumption of tobacco products, physical inactivity, changes in diet plans, air pollution and work pressure.
Based on the product type, the Clot Management Devices market is segmented into Percutaneous Thrombectomy Devices, Embolectomy Balloon Catheters, Catheter-Directed Thrombolysis (CDT) devices, Neurovascular Embolectomy Devices and Inferior vena cava filters. Based on End user Type, the market is segmented into Hospitals and Diagnostic Centres. Based on region, Clot Management Devices market is segmented into North America (US, Canada, Mexico and Rest of North America), Europe (Germany, UK, France, Russia, Spain, Italy and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Singapore, Malaysia and Rest of Asia-Pacific) and Latin America, and Middle East & Africa. North America remained the dominant region in the global Clot Management Devices market in 2015. Asia-Pacific would witness promising CAGR during the forecast period (2016-2022). The report covers the analysis of key stake holders of the Clot Management Devices market.
Key companies profiled in the report include Teleflex Inc., Edwards Lifesciences Corporation, Medtronic Plc, Boston Scientific Corporation, Lemaitre Vascular, Inc., Straub Medical AG, Cook Medical Inc. and Johnson & Johnson.